Amicus Therapeutics (FOLD) Stock Forecast & Price Target

$11.22

-0.25 (-2.18%)

(As of 04:37 PM ET)

Today's Range: $11.19
▼
$11.48
50-Day Range: $9.98
▼
$12.16
52-Week Range: $9.70
▼
$14.10

Volume: 1.87 million shs
Average Volume: 2.41 million shs
Market Capitalization: $3.29 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.17

Amicus Therapeutics Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

$16.17
44.09% Upside

High Forecast	$19.00
Average Forecast	$16.17
Low Forecast	$11.00

Type	Current Forecast 12/8/22 to 12/8/23	1 Month Ago 11/8/22 to 11/8/23	3 Months Ago 9/9/22 to 9/9/23	1 Year Ago 12/8/21 to 12/8/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$16.17	$16.00	$15.20	$14.67
Predicted Upside	44.09% Upside	31.26% Upside	26.08% Upside	53.85% Upside

Get Amicus Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter.

FOLD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

FOLD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Amicus Therapeutics Stock vs. The Competition

Type	Amicus Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.67	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	43.70% Upside	4,384.49% Upside	3,818.99% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/9/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$14.00 ➝ $15.00	+32.04%
9/29/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$17.00 ➝ $19.00	+60.20%
9/29/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$16.00 ➝ $19.00	+60.20%
3/2/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$15.00 ➝ $17.00	+31.58%
3/2/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral	$10.00 ➝ $11.00	-18.82%
1/18/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$14.00 ➝ $16.00	+28.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:45 PM ET.

FOLD Price Target - Frequently Asked Questions

What is Amicus Therapeutics's consensus rating and price target?: According to the issued ratings of 6 analysts in the last year, the consensus rating for Amicus Therapeutics stock is Moderate Buy based on the current 2 hold ratings and 4 buy ratings for FOLD. The average twelve-month price prediction for Amicus Therapeutics is $16.17 with a high price target of $19.00 and a low price target of $11.00. Learn more on FOLD's analyst rating history.
Do Wall Street analysts like Amicus Therapeutics more than its competitors?: Analysts like Amicus Therapeutics less than other Medical companies. The consensus rating score for Amicus Therapeutics is 2.67 while the average consensus rating score for medical companies is 2.68. Learn more on how FOLD compares to other companies.
Does Amicus Therapeutics's stock price have much upside?: According to analysts, Amicus Therapeutics's stock has a predicted upside of 31.83% based on their 12-month stock forecasts.

What analysts cover Amicus Therapeutics?: Amicus Therapeutics has been rated by Bank of America, JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:FOLD) was last updated on 12/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial